Publication | Closed Access
Phase II Trial of Irinotecan (CPT-11) in Relapsed or Refractory Non-Hodgkin's Lymphomas
11
Citations
0
References
2003
Year
Lymphoid NeoplasiaPhase Ii TrialRefractory Non-hodgkinMedicineMalignant Blood DisorderPathologyPharmacotherapyCancer TreatmentOncologyRadiation OncologyCancer Research
No additional data available for this publication yet. Check back later!